Get the Stockscreener App
304.79
0.97%
-2.99
Pre-market:
305.10
0.31
+0.10%
Bio Rad Laboratories Inc stock is traded at $304.79, with a volume of 192.70K.
It is down -0.97% in the last 24 hours and down -1.69% over the past month.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$307.78
Open:
$310.5
24h Volume:
192.70K
Relative Volume:
0.86
Market Cap:
$6.70B
Revenue:
$2.58B
Net Income/Loss:
$-778.69M
P/E Ratio:
-11.15
EPS:
-27.33
Net Cash Flow:
$223.75M
1W Performance:
-6.87%
1M Performance:
-1.69%
6M Performance:
+22.57%
1Y Performance:
-4.95%
1-Day Range:
$301.33
$310.50
1-Week Range:
$296.15
$326.79
52-Week Range:
$211.43
$373.69
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories Inc
Sector
Industry
Phone
(510) 724-7000
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
304.79 | 8.30B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
126.15 | 226.05B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.01 | 147.09B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.23 | 137.49B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.34 | 129.29B | 34.76B | 4.79B | 5.30B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
86.02 | 48.77B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-03-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-07-23 | Initiated | UBS | Buy |
| Jun-16-23 | Initiated | Wells Fargo | Overweight |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jan-28-22 | Reiterated | Citigroup | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-17-18 | Initiated | Goldman | Buy |
| Sep-20-18 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-16-18 | Downgrade | CL King | Buy → Neutral |
| Jul-13-17 | Initiated | Wells Fargo | Outperform |
| Jun-28-17 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-18-17 | Initiated | Deutsche Bank | Hold |
| Oct-13-16 | Initiated | CL King | Buy |
| May-06-15 | Reiterated | Jefferies | Buy |
| Dec-18-09 | Initiated | Maxim Group | Buy |
| Nov-06-09 | Initiated | Jefferies & Co | Buy |
| Jul-17-09 | Initiated | Soleil | Buy |
| Sep-26-07 | Initiated | Banc of America Sec | Buy |
| Feb-23-07 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Bio Rad Laboratories Inc Stock (BIO) Latest News
Will Bio Rad Laboratories Inc. Class stock rise with strong economyEarnings Recap Report & Capital Efficient Trade Techniques - newser.com
Can Bio Rad Laboratories Inc. (BUWA) stock ride next bull market cycle - newser.com
What is the fair value estimate for Bio Rad Laboratories Inc. Class B stock in 2025 - newser.com
Is Bio Rad Laboratories Inc. Class stock at risk of policy regulationMarket Movement Recap & Free Low Drawdown Momentum Trade Ideas - newser.com
Published on: 2025-11-19 22:26:31 - newser.com
What RSI levels show for Bio Rad Laboratories Inc. Class B stock - newser.com
Why Bio Rad Laboratories Inc. Class stock stays on top picks2025 Market Outlook & Low Drawdown Momentum Trade Ideas - newser.com
Is Bio Rad Laboratories Inc. (BUW) stock cheap vs fundamentalsPortfolio Gains Report & Long Hold Capital Preservation Plans - newser.com
Will Bio Rad Laboratories Inc. (BUW) stock see valuation expansion2025 Earnings Impact & Precise Swing Trade Alerts - newser.com
Is Bio Rad Laboratories Inc. Class B stock expanding market penetrationPortfolio Performance Report & Long-Term Investment Growth Plans - newser.com
Is Bio Rad Laboratories Inc. (BUWA) stock a buy during volatile markets2025 Earnings Surprises & High Return Stock Watch Alerts - newser.com
How Bio Rad Laboratories Inc. Class B stock trades pre earningsJuly 2025 Chart Watch & Low Drawdown Investment Ideas - newser.com
What valuation ratios show for Bio Rad Laboratories Inc. (BUWA) stock2025 Earnings Impact & Step-by-Step Trade Execution Guides - newser.com
Is Bio Rad Laboratories Inc. (BUW) stock a good hedge against inflation2025 Winners & Losers & High Accuracy Trade Alerts - newser.com
Exit strategy if you’re trapped in Bio Rad Laboratories Inc.2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Can trapped investors hope for a rebound in Bio Rad Laboratories Inc.2025 Growth vs Value & Scalable Portfolio Growth Methods - newser.com
Is Bio Rad Laboratories Inc. Class B stock supported by free cash flowM&A Rumor & Long-Term Safe Return Strategies - newser.com
Published on: 2025-11-19 13:22:50 - newser.com
Is Bio Rad Laboratories Inc. stock supported by strong cash flowsJuly 2025 Volume & Daily Stock Trend Watchlist - newser.com
Will Bio Rad Laboratories Inc. Class B stock profit from fiscal stimulus2025 Market Overview & Safe Entry Momentum Stock Tips - newser.com
What RSI levels show for Bio Rad Laboratories Inc. Class stockInsider Selling & High Yield Stock Recommendations - newser.com
Research Antibodies & Reagents Market Size, Outlook 2032 by Key - openPR.com
How Bio Rad Laboratories Inc. Class stock reacts to new regulationsJuly 2025 Final Week & Free Expert Approved Momentum Trade Ideas - newser.com
Why Bio Rad Laboratories Inc. (BUW) stock is upgraded to buy2025 Key Lessons & Weekly High Potential Stock Alerts - newser.com
What macro factors could drive Bio Rad Laboratories Inc. Class stock higherJuly 2025 Drop Watch & Consistent Growth Stock Picks - newser.com
Why Bio Rad Laboratories Inc. (BUWA) stock is a must watch tickerJuly 2025 Drop Watch & Daily Profit Maximizing Trade Tips - newser.com
How Bio Rad Laboratories Inc. (BUWA) stock stacks up against competitorsPortfolio Value Report & Real-Time Market Trend Scan - newser.com
How Bio Rad Laboratories Inc. (BUW) stock correlates with oil marketsInflation Watch & Low Risk High Win Rate Stock Picks - newser.com
What earnings margins imply for Bio Rad Laboratories Inc. Class B stockJuly 2025 Spike Watch & Growth Focused Stock Reports - newser.com
What MACD trends signal for Bio Rad Laboratories Inc. (BUWA) stockJuly 2025 Review & Long Hold Capital Preservation Plans - newser.com
Why analysts maintain buy rating on Bio Rad Laboratories Inc. (BUW) stockJuly 2025 Recap & Fast Gain Swing Alerts - newser.com
Is Bio Rad Laboratories Inc. (BUWA) stock positioned for secular growthJuly 2025 Reactions & Short-Term High Return Strategies - newser.com
How Bio Rad Laboratories Inc. (BUWA) stock performs in volatility spikes2025 Short Interest & Stepwise Entry/Exit Trade Alerts - newser.com
What to expect from Bio Rad Laboratories Inc. in the next 30 daysEarnings Miss & Breakout Confirmation Alerts - newser.com
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.73%
3.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):